BioPharma Credit PLC STATEMENT RE IMMUNOGEN, INC.
13 Febrero 2024 - 1:00AM
RNS Regulatory News
RNS Number : 9464C
BioPharma Credit PLC
13 February 2024
BioPharma Credit PLC
13 February 2024
BIOPHARMA
CREDIT PLC
(THE
"COMPANY")
STATEMENT
RE ImmunoGen, Inc.
Pharmakon Advisors, LP, the
investment manager of the Company, notes the
announcement released 12 February 2024 by AbbVie Inc. ("AbbVie")
regarding the completion of its acquisition of ImmunoGen, Inc.
("IMGN") (such acquisition, the "Transaction"). AbbVie and IMGN had
previously announced the entering into of a definitive agreement
regarding the Transaction on Thursday 30 November 2023.
The Company announced on 11 April
2023 an investment in a senior secured loan to IMGN of up to
US$62.5 million in up to two tranches. The Company had previously
funded the first tranche representing a US$37.5 million investment,
which was prepaid upon the closing of the Transaction. The Company
received US$50.6 million in total, including $13.1 million of
accrued interest, additional consideration, and prepayment and
make-whole fees.
Enquiries:
BioPharma Credit plc
via Link Company Matters
Limited
Company Secretary
+44 (0)1392 477 509
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
STRGPUUCPUPCUQW
Biopharma Credit (LSE:BPCR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Biopharma Credit (LSE:BPCR)
Gráfica de Acción Histórica
De May 2023 a May 2024